Showing results (31-40 of 157) with videos related to
Sort By:
Pageof 16
Molecular Endocrinology (Baltimore, Md.)|April 9, 2011
Differential recruitment of nuclear coregulators directs the isoform-dependent action of mutant thyroid hormone receptorsLaura Fozzatti, Changxue Lu, Dong-Wook Kim, et al.Steroids|November 19, 2008
Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptorsFumihiko Furuya, Changxue Lu, Celine J Guigon, et al.American Journal of Cancer Research|August 9, 2019
Monocyte recruitment and activated inflammation are associated with thyroid carcinogenesis in a mouse modelSunmi Park, Jack Zhu, Grégoire Altan-Bonnet, et al.Oncotarget|April 30, 2015
Oncogenic mutations of thyroid hormone receptor βJeong Won Park, Li Zhao, Mark Willingham, et al.Endocrinology|March 22, 2008
Activation of phosphatidylinositol 3-kinase signaling promotes aberrant pituitary growth in a mouse model of thyroid-stimulating hormone-secreting pituitary tumorsChangxue Lu, Mark C Willingham, Fumihiko Furuya, et al.Endocrine-Related Cancer|June 20, 2018
Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancerSunmi Park, Mark C Willingham, Jun Qi, et al.Oncotarget|October 3, 2014
Src-dependent phosphorylation at Y406 on the thyroid hormone receptor β confers the tumor suppressor activityJeong Won Park, Li Zhao, Paul Webb, et al.Endocrine-Related Cancer|July 5, 2019
Potentiated anti-tumor effects of BETi by MEKi in anaplastic thyroid cancerXuguang Zhu, Sunmi Park, Woo Kyung Lee, et al.Carcinogenesis|July 31, 2007
Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancerFumihiko Furuya, Changxue Lu, Mark C Willingham, et al.Journal of Molecular Endocrinology|January 19, 2010
Adipogenesis is differentially impaired by thyroid hormone receptor mutant isoformsAlok Mishra, Xu-Guang Zhu, Kai Ge, et al.Pageof 16